Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)
About this filing
Lexeo Therapeutics, Inc. (LXEO) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Nov 16, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More LXEO filings
- 4
Filed Nov 17, 2026
- 3
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
- SC 13G/A
Filed Nov 16, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.